论文部分内容阅读
丽珠肠乐（Bifidobiogen）是微生态调节新药。为评价其对急性腹泻的疗效，本文用该药治疗57例各种原因所致的急性腹泻患者，并与氟哌酸对照组进行了比较，现报告如下。l材料和方法1．1病例选择：1O3例患者均为我院1996年l～11月内科门诊不同原因所致的急性腹泻患者，随机分成丽
Bifidobiogen is a new microbiologically regulated drug. In order to evaluate its curative effect on acute diarrhea, 57 cases of acute diarrhea caused by various causes were treated with this drug and compared with norfloxacin control group, the report is as follows. l Materials and Methods 1.1 Case Selection: 1O3 patients were hospital for l- November 1996 out-patient different causes of acute diarrhea patients were randomly divided into beautiful